ADDF in the News
Read current and past news articles about the Alzheimer’s Drug Discovery Foundation.
Dr. Howard Fillit provided commentary on how the FDA approval of the first blood test for Alzheimer’s will revolutionize clinical care and clinical research.
Dr. Howard Fillit discusses the FDA approval of the first blood test for Alzheimer's disease.
ADDF’s Harris On Alzheimer’s Outlook And Investment
March 10, 2025
Karen Harris, Chief Financial Officer & Head of Mission Related Investments shares insight into ADDF’s investment strategy built around a venture philanthropy model and the growing biopharma interest in Alzheimer’s research.
Aging and Alzheimer’s: Where is the Science, Where are we Heading?
February 12, 2025
Mark Roithmayr, CEO joined leaders from biopharma, policy, and research in Riyadh to discuss the current treatment and prevention landscape for Alzheimer’s disease.
Dr. Howard Fillit provides commentary on Biogen's decision to abandon Aduhelm, noting how this was more of a commercial than a scientific decision, and offering insights on how the handling of the program led to uncertainty about the drug.
Alzheimer's Drug Discovery Foundation
A GuideStar-Rated Charity
New York, NY 10019
info@alzdiscovery.org
212.901.8000
© Copyright 2025. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).